Ventana Medical Systems of Tucson, Arizona has sought approval of the FDA for a test that the company says can aid in breast cancer treatment.
The test, called “Inform HER2” is already in use in Asia, Europe, Canada and Australia. The company is seeking FDA approval to sell the test in the United States.
The test is used to detect a gene in breast cancer tissue and assess whether patients are likely to respond to the drug Herceptin for treatment. Check it out at http://www.ventanamed.com/.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment